|Tel||+44 (0)1865 612635|
Richard Williams has worked at the Kennedy Institute of Rheumatology since 1989 and was a Senior Lecturer (2007-2011) and then Reader (2011-2012) at Imperial College London before joining the University of Oxford.
He is also a Visiting Lecturer at University College London, Queen Mary University of London and the London School of Hygiene and Tropical Medicine and was recently appointed as an Editor of Arthritis Research and Therapy.
He has established an internationally recognised reputation in translational research and his early studies were instrumental in the development of TNF blocking biologics.
He has carried out numerous projects with British and overseas industrial partners, including Merck, Pfizer, GSK, UCB, Schering, Celgene and J&J and has led an MRC DPFS project on rheumatoid arthritis.
McCann FE. et al, (2014), Arthritis Rheumatol, 66, 2728 - 2738
Cribbs AP. et al, (2014), Arthritis Rheumatol, 66, 2344 - 2354
Alzabin S. et al, (2012), Ann Rheum Dis, 71, 1741 - 1748
Criado G. et al, (2009), Arthritis Rheum, 60, 1342 - 1351
Notley CA. et al, (2008), J Exp Med, 205, 2491 - 2497
Hull DN. et al, (2016), Arthritis Res Ther, 18
Hull DN. et al, (2016), ARTHRITIS RESEARCH & THERAPY, 18
Bystrom J. et al, (2016), Cytokine
Kawalkowska J. et al, (2016), Sci Rep, 6
Kawalkowska JZ. et al, (2016), Eur J Immunol, 46, 1246 - 1257